Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1526
Insmed
INSM
$21B
| $18.9M | 0.01% |
772,060
+283,758
| +58% | +$6.44M |
2013 Q2
8 quarters
|
|
1527
Iron Mountain
IRM
$33.5B
| $18.9M | 0.01% |
608,222
-543,466
| -47% | -$19M |
2013 Q2
8 quarters
|
|
1528
Nabors Industries
NBR
$1.19B
| $18.8M | 0.01% |
26,094
+9,144
| +54% | +$6.89M |
2013 Q2
8 quarters
|
|
|
ALU
1529
DELISTED
Alcatel-Lucent
ALU
| $18.8M | 0.01% |
5,196,816
+1,596,412
| +44% | +$6.13M |
2013 Q2
8 quarters
|
|
1530
Bloomin' Brands
BLMN
$852M
| $18.8M | 0.01% |
879,436
+242,085
| +38% | +$5.45M |
2013 Q2
8 quarters
|
|
|
FRC
1531
DELISTED
First Republic Bank
FRC
| $18.7M | 0.01% |
297,275
+74,131
| +33% | +$4.48M |
2013 Q2
8 quarters
|
|
|
CBPO
1532
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $18.7M | 0.01% |
162,558
+11,626
| +8% | +$1.22M |
2013 Q2
8 quarters
|
|
1533
BlackRock Multi-Sector Income Trust
BIT
$633M
| $18.7M | 0.01% |
1,128,728
-110,356
| -9% | -$1.91M |
2013 Q2
8 quarters
|
|
1534
UDR
UDR
$11B
| $18.7M | 0.01% |
584,161
+201,834
| +53% | +$6.63M |
2013 Q2
8 quarters
|
|
1535
Citi Trends
CTRN
$406M
| $18.7M | 0.01% |
772,161
-26,405
| -3% | -$654K |
2013 Q2
8 quarters
|
|
1536
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.44B
| $18.7M | 0.01% |
326,538
-3,774
| -1% | -$221K |
2013 Q2
8 quarters
|
|
1537
Jones Lang LaSalle
JLL
$14.1B
| $18.6M | 0.01% |
109,030
-32,263
| -23% | -$5.45M |
2013 Q2
8 quarters
|
|
|
DJCI
1538
DELISTED
ETRACS Linked to the Bloomberg Commodity Index Total Return due October 31, 2039
DJCI
| $18.6M | 0.01% |
998,529
+3,629
| +0.4% | +$67.8K |
2013 Q2
8 quarters
|
|
1539
Cohen & Steers Closed End Opportunity Fund
FOF
$341M
| $18.6M | 0.01% |
1,537,650
+220,375
| +17% | +$2.85M |
2013 Q2
8 quarters
|
|
1540
Synopsys
SNPS
$87.1B
| $18.6M | 0.01% |
366,928
+11,464
| +3% | +$558K |
2013 Q2
8 quarters
|
|
1541
Middleby
MIDD
$4.87B
| $18.6M | 0.01% |
165,560
-22,898
| -12% | -$2.45M |
2013 Q2
8 quarters
|
|
1542
UGI
UGI
$8.24B
| $18.6M | 0.01% |
538,728
-490,876
| -48% | -$17.4M |
2013 Q2
8 quarters
|
|
1543
Vanguard Utilities ETF
VPU
$8.2B
| $18.5M | 0.01% |
206,259
+16,290
| +9% | +$1.55M |
2013 Q2
8 quarters
|
|
1544
Cabot Corp
CBT
$3.84B
| $18.5M | 0.01% |
497,286
+272,280
| +121% | +$11.7M |
2013 Q2
8 quarters
|
|
1545
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$335M
| $18.5M | 0.01% |
71,154
-1,629
| -2% | -$457K |
2013 Q2
8 quarters
|
|
1546
Agios Pharmaceuticals
AGIO
$1.87B
| $18.5M | 0.01% |
166,776
-21,165
| -11% | -$2.28M |
2013 Q3
7 quarters
|
|
1547
First Trust Germany AlphaDEX Fund
FGM
$89.8M
| $18.5M | 0.01% |
488,712
+238,903
| +96% | +$9.32M |
2013 Q2
8 quarters
|
|
|
NEWR
1548
DELISTED
New Relic, Inc.
NEWR
| $18.5M | 0.01% |
525,869
+271,924
| +107% | +$8.88M |
2014 Q4
2 quarters
|
|
1549
First Trust Emerging Markets AlphaDEX Fund
FEM
$792M
| $18.5M | 0.01% |
805,733
+214,854
| +36% | +$5.23M |
2013 Q2
8 quarters
|
|
1550
Vanda Pharmaceuticals
VNDA
$244M
| $18.5M | 0.01% |
1,457,511
+36,397
| +3% | +$393K |
2013 Q2
8 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.